Cardiovascular Safety of Azithromycin in Patients Hospitalized With COVID-19: A Prespecified Pooled Analysis of the COALITION I and COALITION II Randomized Clinical Trials.

MLA

Furtado, Remo H. M., et al. “Cardiovascular Safety of Azithromycin in Patients Hospitalized With COVID-19: A Prespecified Pooled Analysis of the COALITION I and COALITION II Randomized Clinical Trials.” The American Journal of Cardiology, vol. 214, Mar. 2024, pp. 18–24. EBSCOhost, https://doi.org/10.1016/j.amjcard.2023.11.069.

APA

Furtado, R. H. M., Barros E Silva, P. G. M., Fonseca, H. A. R., Serpa-Neto, A., Correa, T. D., Guimarães, H. P., Pereira, A. J., Olivato, G. B., Zampieri, F. G., Lisboa, T., Junqueira, D. L. M., Lapa, M. G., Monfardini, F., Damiani, L. P., Echenique, L. S., Gebara, O. E., Hoffman Filho, C. R., Polanczyk, C. A., Rohde, L. E., … Berwanger, O. (2024). Cardiovascular Safety of Azithromycin in Patients Hospitalized With COVID-19: A Prespecified Pooled Analysis of the COALITION I and COALITION II Randomized Clinical Trials. The American Journal of Cardiology, 214, 18–24. https://doi.org/10.1016/j.amjcard.2023.11.069

Chicago

Furtado, Remo H M, Pedro G M Barros E Silva, Henrique A R Fonseca, Ary Serpa-Neto, Thiago D Correa, Hélio P Guimarães, Adriano J Pereira, et al. 2024. “Cardiovascular Safety of Azithromycin in Patients Hospitalized With COVID-19: A Prespecified Pooled Analysis of the COALITION I and COALITION II Randomized Clinical Trials.” The American Journal of Cardiology 214 (March): 18–24. doi:10.1016/j.amjcard.2023.11.069.